AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis

RecruitingNAAges 18 Years - anyAllWellSpan Health
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this interventional, prospective study is to determine the clinical utility of a repeat point-of-care ultrasound of the gallbladder in adult emergency department patients with abdominal pain for which initial imaging is not diagnostic. The main question it aims to answer is: Does a repeat ultrasound improve early identification of gallbladder inflammation? Participants will undergo a repeat ultrasound of the gallbladder while still in the emergency department and will be followed up to determine subsequent diagnoses, disposition, consultations and other clinical information.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * โ‰ฅ 18 years of age * Presenting to the emergency department with abdominal pain with clinical concern for possible acute cholecystitis * Initial biliary US interpreted as normal, equivocal or negative for acute cholecystitis * 2-6 hours since initial biliary ultrasound with ongoing symptoms * General surgery consult placed or additional non-ultrasound advanced imaging ordered * Fluency in English or Spanish Exclusion Criteria: * \< 18 years of age * \> 6 hours since initial biliary US * Asymptomatic/resolved symptoms or pending discharge from the emergency department * Initial ultrasound positive for acute cholecystitis or other findings to explain presenting symptoms * Baseline ascites * Prior cholecystectomy * Unable or unwilling to provide consent * Presenting to a facility other than study site emergency department * Transferred patients from outside facilities
๐Ÿ’Š

What it tests

  • Repeat biliary point of care ultrasound
๐Ÿ“

Where

1 site
WellSpan Health York Hospital
York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy